effect on blood glucose Blood glucose postprandial hyperglycemia
Conditions
Interventions
Two different investigational treatments will be consumed:
* Treatment 1 (P1): A wheat product (containing 2% 13C-universally-labeled
wheat) with natural extract added.
* Treatment 2 (G): A solution
Sponsors
Unilever
Eligibility
Age
18 Years to 99 Years
Inclusion criteria
Inclusion criteria: 1. Informed consent signed. 2. Healthy Caucasian male. 3. Age at start of the study * 20 and * 50 years. 4. Body mass index (BMI) * 18.0 and * 25.0 kg/m2.
Exclusion criteria
Exclusion criteria: 1. Use of antibiotics within 3 months before Day 1; use of any other medication except paracetamol within 14 days before Day 1. 2. Reported intense sporting activities > 10h/w. 3. Not being used to eat breakfast.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| EFFICACY ENDPOINTS: In plasma: 1. 13C- and 2H-enrichment (mo * m6) of glucose (Gas Chromatography/Mass Spectrometry; GC/MS) 2. Total blood glucose (BG) 3. Insulin | — |
Countries
Netherlands
Outcome results
None listed